(VIANEWS) – First Bank (FRBA), WD-40 Company (WDFC), Neurocrine Biosciences (NBIX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. First Bank (FRBA)
32.1% sales growth and 13.05% return on equity
First Bank provides various banking products and services to individuals, businesses, and governmental entities. The company accepts various deposits, including non-interest bearing demand deposits, interest bearing demand accounts, money market accounts, savings accounts, and certificates of deposit, as well as commercial checking accounts. Its loan products include commercial and industrial loans; commercial real estate loans, such as owner-occupied, investor, construction and development, and multi-family loans; residential real estate loans comprising residential mortgages, first and second lien home equity loans, and revolving lines of credit; and consumer and other loans that include auto, personal, and traditional installment loans. The company also provides electronic banking services, including Internet and mobile banking, electronic bill payment, and banking by phone, as well as ATM and debit cards, and wire and ACH transfer services; remote deposit capture; and cash management services. As of December 31, 2021, it operated 18 full-service branches in Cinnaminson, Cranbury, Delanco, Denville, Ewing, Flemington, Hamilton, Hamilton, Lawrence, Mercerville, Pennington, Randolph, Somerset, and Williamstown counties in New Jersey, as well as Doylestown, Trevose, Warminster, and West Chester counties in Pennsylvania. First Bank was incorporated in 2007 and is headquartered in Hamilton, New Jersey.
Earnings Per Share
As for profitability, First Bank has a trailing twelve months EPS of $1.81.
PE Ratio
First Bank has a trailing twelve months price to earnings ratio of 6.39. Meaning, the purchaser of the share is investing $6.39 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.05%.
Volume
Today’s last reported volume for First Bank is 34081 which is 26.31% below its average volume of 46250.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 2.19%.
Sales Growth
First Bank’s sales growth is 15.7% for the ongoing quarter and 32.1% for the next.
Moving Average
First Bank’s worth is way below its 50-day moving average of $13.40 and way below its 200-day moving average of $14.36.
2. WD-40 Company (WDFC)
22.5% sales growth and 32.21% return on equity
WD-40 Company develops and sells maintenance products, and homecare and cleaning products in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company offers multi-purpose maintenance products, including aerosol sprays, non-aerosol trigger sprays, and in liquid-bulk form products under the WD-40 Multi-Use brand name for various consumer uses and industrial applications; and specialty maintenance products, such as penetrants, degreasers, corrosion inhibitors, greases, lubricants, and rust removers under the WD-40 Specialist brand, as well as various products under the WD-40 Bike brand name. It also provides multi-purpose and specialty drip oils, and spray lubricant products, as well as other specialty maintenance products under the 3-IN-ONE brand name; and professional spray maintenance products and lubricants for the bike market under the GT85 brand name. In addition, the company offers automatic toilet bowl cleaners under the 2000 Flushes brand name; aerosol and liquid trigger carpet stain and odor eliminators under the Spot Shot brand; room and rug deodorizers under the Carpet Fresh brand name; carpet and household cleaners, and rug and room deodorizers under the 1001 brand; heavy-duty hand cleaner products under the Lava brand name in the United States, as well as under the Solvol brand name in Australia; and liquid mildew stain removers and automatic toilet bowl cleaners under the X-14 brand name. It sells its products primarily through warehouse club stores, hardware stores, automotive parts outlets, industrial distributors and suppliers, mass retail and home center stores, value retailers, grocery stores, online retailers, farm supply, sport retailers, and independent bike dealers. WD-40 Company was founded in 1953 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, WD-40 Company has a trailing twelve months EPS of $4.49.
PE Ratio
WD-40 Company has a trailing twelve months price to earnings ratio of 38.28. Meaning, the purchaser of the share is investing $38.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.21%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 11, 2023, the estimated forward annual dividend rate is 3.32 and the estimated forward annual dividend yield is 1.89%.
3. Neurocrine Biosciences (NBIX)
17.7% sales growth and 10.03% return on equity
Neurocrine Biosciences, Inc., a neuroscience-focused biopharmaceutical company, discovers, develops, and delivers various treatments for people with neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products also include ONGENTYS, a catechol-O-methyltransferase inhibitor used as an adjunct therapy to levodopa/DOPA decarboxylase inhibitors for patients with Parkinson's disease; ORILISSA for the management of moderate to severe endometriosis pain in women; and ORIAHNN, a non-surgical oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. Its product candidates in clinical development include NBI-921352 for treating pediatric patients, as well as adult focal epilepsy indications; NBI-827104 to treat rare pediatric epilepsy and other indications; and crinecerfont. The company's products in clinical development also comprise NBI-1065844 for the treatment of negative symptoms of schizophrenia; NBI-1065845 for the treatment of resistant depression; and NBI-1065846 for treating anhedonia in depression. It has license and collaboration agreements with Takeda Pharmaceutical Company Limited; Idorsia Pharmaceuticals Ltd; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; BIAL – Portela & Ca, S.A.; Mitsubishi Tanabe Pharma Corporation; AbbVie Inc.; and Sentia Medical Sciences Inc. Neurocrine Biosciences, Inc. was incorporated in 1992 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, Neurocrine Biosciences has a trailing twelve months EPS of $1.54.
PE Ratio
Neurocrine Biosciences has a trailing twelve months price to earnings ratio of 61.2. Meaning, the purchaser of the share is investing $61.2 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.03%.
Moving Average
Neurocrine Biosciences’s value is way under its 50-day moving average of $104.76 and way under its 200-day moving average of $106.74.
Yearly Top and Bottom Value
Neurocrine Biosciences’s stock is valued at $94.25 at 06:22 EST, way below its 52-week high of $129.29 and way higher than its 52-week low of $75.25.
4. Ormat Technologies (ORA)
17.4% sales growth and 4.01% return on equity
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guatemala, New Zealand, Honduras, and internationally. The company operates through three segments: Electricity, Product, and Energy Storage and Management Services. The Electricity segment develops, builds, owns, and operates geothermal, solar photovoltaic (PV), and recovered energy-based power plants; and sells electricity. The Product segment designs, manufactures, and sells equipment for geothermal, recovered energy-based electricity generation, and remote power units, such as fossil fuel powered turbo-generators and heavy duty direct-current generators. This segment also provides services relating to the engineering, procurement, construction, operation, and maintenance of geothermal, solar PV, and recovered energy-based power plants. The Product segment serves contractors; developers, owners, and operators of geothermal power plants; and owners and operators of interstate natural gas pipelines, gas processing plants, and cement plants, as well as companies in other energy-intensive industrial processes. The Energy Storage and Management Services segment offers energy storage, demand response, and energy management related services, as well as services relating to the engineering, procurement, construction, operation, and maintenance of energy storage units. Ormat Technologies, Inc. was founded in 1965 and is based in Reno, Nevada.
Earnings Per Share
As for profitability, Ormat Technologies has a trailing twelve months EPS of $1.65.
PE Ratio
Ormat Technologies has a trailing twelve months price to earnings ratio of 51.06. Meaning, the purchaser of the share is investing $51.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.01%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 17.1% and 54.3%, respectively.
5. Nustar Energy L.P. (NS)
7.5% sales growth and 15.11% return on equity
NuStar Energy L.P. engages in the terminalling, storage, and marketing of petroleum products in the United States and internationally. The company also engages in the transportation of petroleum products and anhydrous ammonia. It operates through three segments: Pipeline, Storage, and Fuels Marketing. The Pipeline segment transports refined petroleum products, crude oil, and anhydrous ammonia. The Storage segment owns terminal and storage facilities, which offer storage, handling, and other services for petroleum products, crude oil, specialty chemicals, and other liquids. This segment also provides pilotage, tug assistance, line handling, launch, emergency response, and other ship services. The Fuels Marketing segment is involved in bunkering operations in the Gulf Coast; blending operations; and purchase of petroleum products for resale. As of December 31, 2019, the company had 3,205 miles of refined product pipelines and 2,155 miles of crude oil pipelines in Texas, Oklahoma, Kansas, Colorado, and New Mexico; a 2,150-mile refined product pipeline originating in southern Kansas and terminating at Jamestown, North Dakota; a 450-mile refined product pipeline originating at Marathon Petroleum Corporation's Mandan, North Dakota refinery and terminating in Minneapolis, Minnesota; 2,000 miles of anhydrous ammonia pipelines; and 40 terminal and storage facilities, which offer approximately 61.3 million barrels of storage capacity. NuStar Energy L.P. was founded in 1999 and is headquartered in San Antonio, Texas.
Earnings Per Share
As for profitability, Nustar Energy L.P. has a trailing twelve months EPS of $0.36.
PE Ratio
Nustar Energy L.P. has a trailing twelve months price to earnings ratio of 43.5. Meaning, the purchaser of the share is investing $43.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.11%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 6, 2023, the estimated forward annual dividend rate is 1.6 and the estimated forward annual dividend yield is 10.3%.
Volume
Today’s last reported volume for Nustar Energy L.P. is 141737 which is 63.3% below its average volume of 386280.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 222.7% and 50%, respectively.
6. China Automotive Systems (CAAS)
6.5% sales growth and 7.11% return on equity
China Automotive Systems, Inc., through its subsidiaries, manufactures and sells automotive systems and components in the People's Republic of China. It produces rack and pinion power steering gears for cars and light-duty vehicles; integral power steering gears for heavy-duty vehicles; power steering parts for light duty vehicles; sensor modules; automobile steering systems and columns; and automobile electronic and hydraulic power steering systems and parts. The company also offers automotive motors and electromechanical integrated systems; polymer materials; and intelligent automotive technology research and development services. In addition, it provides after sales services, and research and development support services, as well as markets automotive parts in North America and Brazil. The company primarily sells its products to the original equipment manufacturing customers. China Automotive Systems, Inc. was incorporated in 1999 and is headquartered in Jingzhou, the People's Republic of China.
Earnings Per Share
As for profitability, China Automotive Systems has a trailing twelve months EPS of $-0.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.11%.
Volume
Today’s last reported volume for China Automotive Systems is 123536 which is 38.7% below its average volume of 201532.
Moving Average
China Automotive Systems’s value is way below its 50-day moving average of $7.33 and way above its 200-day moving average of $4.87.
Revenue Growth
Year-on-year quarterly revenue growth grew by 26.8%, now sitting on 539.58M for the twelve trailing months.
